In silico Identification of Novel EGFR Inhibitors with Antiproliferative Activity Against Cancer Cells.
โ Scribed by Claudio N. Cavasotto; Maria A. Ortiz; Ruben A. Abagyan; F. Javier Piedrafita
- Publisher
- John Wiley and Sons
- Year
- 2006
- Weight
- 10 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Inosine 5โmonophosphate dehydrogenase II, a key enzyme in the __de novo__ synthesis of purine nucleotides, is expressed in prostate tumors and prostate cancer cells. AVN944 is a new, specific, noncompetitive IMPDH inhibitor. In this study, we investigated the effects of IMPDH inhibitor
## Abstract CDC25 phosphatases are key actors in cyclinโdependent kinases activation whose role is essential at various stages of the cell cycle. CDC25 expression is upregulated in a number of human cancers. CDC25 phosphatases are therefore thought to represent promising novel targets in cancer the
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a โFull Textโ option. The original article is trackable v